<DOC>
	<DOCNO>NCT02083640</DOCNO>
	<brief_summary>This study assess relative bioavailability palbociclib hard gelatin capsule formulation ( API 41 micrometer dissolution Level 1 ) palbociclib hard gelatin capsule formulation ( API 16 micrometer dissolution Level 2 ) compare palbociclib hard gelatin capsule formulation ( API 16 micrometer dissolution Level 1 ) single 125 mg oral dos feed condition healthy volunteer .</brief_summary>
	<brief_title>Relative Bioavailability For Palbociclib Formulations</brief_title>
	<detailed_description />
	<mesh_term>Palbociclib</mesh_term>
	<criteria>Healthy male subject and/or female subject physical possibility get pregnant . Evidence personally sign date informed consent document indicate subject ( legal representative ) inform pertinent aspect study . Subjects willing able comply schedule visit , treatment plan , laboratory test , study procedure . Evidence history clinically significant hematological , renal , endocrine , pulmonary , gastrointestinal , cardiovascular , hepatic , psychiatric , neurologic , allergic disease . Any condition possibly affect drug absorption ( eg , gastrectomy ) . A positive urine drug screen . History regular alcohol consumption exceed 7 drinks/week female 14 drinks/week male ( 1 drink = 5 ounce ( 150 mL ) wine 12 ounce ( 360 mL ) beer 1.5 ounce ( 45 mL ) hard liquor ) within 6 month Screening . Treatment investigational drug within 30 day ( determined local requirement , whichever long ) precede first dose study medication . Pregnant female ; breastfeed female ; females physical possibility get pregnant .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>healthy volunteer</keyword>
	<keyword>bioavailability</keyword>
	<keyword>palbociclib</keyword>
	<keyword>formulation</keyword>
</DOC>